This is a working overview of freeze-thaw cycling, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-01-27 and is reviewed periodically as new material appears.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 0.9 kDa | Depends on exact fragment sequence and counterion |
| Amino acid sequence | LKKTETQ (commonly cited) | Short actin-binding motif from thymosin beta-4 |
| Common salt form | Acetate salt | Trifluoroacetate also reported in research material |
| Reconstitution solvent | Sterile water or buffer | Gentle mixing; avoid vigorous agitation |
| Solution storage | -20 °C or lower | Aliquot to avoid repeated freeze-thaw cycles |
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Take white (Yemeni) alum, dissolve it and purify it by filtration. Then distil (green?) vitriol with copper-green (the acetate), and mix (the distillate) with the filtered solution of the purified alum, afterwards let it solidify (or crystallise) in the glass beaker. You will get the best qalqadis (white alum) that may be had. In an anonymous Latin work variously attributed to Aristotle (under the title Liber Aristotilis, 'Book of Aristotle'), to al-Razi (under the title Lumen luminum magnum, 'Great Light of Lights'), or to Ibn Sina, the author speaks of an 'oil' (oleum) obtained through the distillation of iron(II) sulfate (green vitriol), which was likely 'oil of vitriol' or sulfuric acid. The work refers multiple times to Jabir ibn Hayyan's Seventy Books (Liber de septuaginta), one of the few Arabic Jabir works that were translated into Latin. The author of the version attributed to al-Razi also refers to the Liber de septuaginta as his own work, showing that he erroneously believed the Liber de septuaginta to be a work by al-Razi. There are several indications that the anonymous work was an original composition in Latin, although according to one manuscript it was translated by a certain Raymond of Marseilles, meaning that it may also have been a translation from the Arabic. According to Ahmad Y. al-Hassan, three recipes for sulfuric acid occur in an anonymous Garshuni manuscript containing a compilation taken from several authors and dating from before c. 1100 AD. One of them runs as follows:
=== ColdFusion 5 === Version 5 was released in June 2001, adding enhanced query support, new reporting and charting features, user-defined functions, and improved admin tools. It was the last to be legacy coded for a specific platform, and the first release from Macromedia after their acquisition of Allaire Corporation, which had been announced January 16, 2001.
In 2012, two independent efforts have elucidated the molecular architecture of the 26S proteasome by single particle electron microscopy. In 2016, three independent efforts have determined the first near-atomic resolution structure of the human 26S proteasome in the absence of substrates by cryo-EM. In the heart of the 19S, directly adjacent to the 20S, are the AAA-ATPases (AAA proteins) that assemble to a heterohexameric ring of the order Rpt1/Rpt2/Rpt6/Rpt3/Rpt4/Rpt5. This ring is a trimer of dimers: Rpt1/Rpt2, Rpt6/Rpt3, and Rpt4/Rpt5 dimerize via their N-terminal coiled-coils. These coiled-coils protrude from the hexameric ring. The largest regulatory particle non-ATPases Rpn1 and Rpn2 bind to the tips of Rpt1/2 and Rpt6/3, respectively. The ubiquitin receptor Rpn13 binds to Rpn2 and completes the base sub-complex. The lid covers one half of the AAA-ATPase hexamer (Rpt6/Rpt3/Rpt4) and, unexpectedly, directly contacts the 20S via Rpn6 and to lesser extent Rpn5. The subunits Rpn9, Rpn5, Rpn6, Rpn7, Rpn3, and Rpn12, which are structurally related among themselves and to subunits of the COP9 complex and eIF3 (hence called PCI subunits) assemble to a horseshoe-like structure enclosing the Rpn8/Rpn11 heterodimer. Rpn11, the deubiquitinating enzyme, is placed at the mouth of the AAA-ATPase hexamer, ideally positioned to remove ubiquitin moieties immediately before translocation of substrates into the 20S. The second ubiquitin receptor identified to date, Rpn10, is positioned at the periphery of the lid, near subunits Rpn8 and Rpn9.
BSA can be calculated on the basis of weight and height. Twenty-four-hour urine collection to assess creatinine clearance is no longer widely performed, due to difficulty in assuring complete specimen collection. To assess the adequacy of a complete collection, one always calculates the amount of creatinine excreted over a 24-hour period. This amount varies with muscle mass and is higher in young people/old, and in men/women. An unexpectedly low or high 24-hour creatinine excretion rate voids the test. Nevertheless, in cases where estimates of creatinine clearance from serum creatinine are unreliable, creatinine clearance remains a useful test. These cases include "estimation of GFR in individuals with variation in dietary intake (vegetarian diet, creatine supplements) or muscle mass (amputation, malnutrition, muscle wasting), since these factors are not specifically taken into account in prediction equations." A number of formulae have been devised to estimate GFR or Ccr values on the basis of serum creatinine levels. Where not otherwise stated serum creatinine is assumed to be stated in mg/dL, not μmol/L—divide by 88.4 to convert from μmol/Lto mg/dL.
Sources: en.wikipedia.org
=== Swimming and undulatory locomotion === The skin of these animal that use undulatory motion to locomote have several distinct characteristics. The skin of these animals consists of cross-helical arrangement of collagen and elastin fibers embedded in the dermal layer of skin, a two-dimensional stiffness. which permits bending at small curvatures and resists bending at high curvatures and skin is attached directly to the underlying muscles. Fish, shark, and snakes are all examples of animals that locomote using undulatory locomotion.
=== Cystine === Cystine is a dimer consisting of two cysteine molecules and the formation of a disulfide bond. This amino acid is a rate limiting substrate used in the SLC7A11 cystine/glutamate transporter and is usually imported into the cell. Cysteine-158 is specifically used in the formation of the disulfide bridge for the protein structure of system Xc-. There are neurotoxins, such as BMAA, that can prevent the intake of cystine, which can lead to decreased extracellular glutamate levels and an increase in oxidative stress.
Alexander was born in Suite 212 of Claridge's Hotel in Brook Street, Mayfair, London, on 17 July 1945. The British Government is said to have temporarily ceded sovereignty over the suite in which the birth occurred to Yugoslavia so that the crown prince would be born on Yugoslav territory, though the story may be apocryphal, as there exists no documentary record of this. Another part of the story says that a box of soil from the homeland was placed under the bed, so the Prince could be born on Yugoslav soil. It is now Suite 214 and known as the 'Alexander Suite'. He was the only child of King Peter II and Queen Alexandra of Yugoslavia. He was christened on 24 October at Westminster Abbey. His godparents were members of the British royal family, King George VI and Princess Elizabeth, who later became Queen Elizabeth II. His parents were relatively unable to take care of him due to their various health and financial problems, so Alexander was raised by his maternal grandmother, Princess Aspasia of Greece and Denmark. He was educated at Trinity School, Institut Le Rosey, Culver Military Academy, Gordonstoun, Millfield and Mons Officer Cadet School, Aldershot, and pursued a career in the British military.
Between 1978 and 1979 Channon designed and fabricated an insulin pump driven by a small compression spring with a programmable bore to allow different rates of insulin infusion. Channon tested this device on himself in what is believed to be the first time a background bolus regime was used to treat an insulin dependent diabetic. The device is now part of the Bristol Museums Collection. With the support of two National Medical Research fund (now WellChild) grants - £26,000 to Channon to fund his secondment and £40,000 to Guy's to support the clinical evaluation - Channon developed a compact insulin infusion pump "no larger than a pocket cigarette lighter" and weighing just three ounces. The pump could be set to a 3-stage decaying programme, which automatically delivered 3 infusions during the day with a successively lower dose on the 2nd and 3rd. In addition the user could manually operate the device when required to cope with the additional insulin required when eating a meal. Channon's work received national, regional and professional coverage including articles in the Times, the Telegraph, New Scientist and the bulletin of the Institute of Marine Engineers. In 1981 the work was featured in the national magazine of Diabetes UK. Following a suggestion by Professor Keen, Channon also developed a 5ml syringe with a precision engineered mechanism for delivering doses of insulin with an audible and tactile click on each rotation of a knurled thimble, for use by blind and deaf-blind diabetics.
== Professional sphere == Women obtained the legal right to work without spousal authorization under the law of July 13, 1965, which came into effect on 1 February 1966. As of recent data (excluding Mayotte), 68.2% of women aged 15–64 were active in the labor market, compared to 75.8% of men in the same age group. According to a CFTC report, 49% of women reported that having a child significantly affected their employment situation, compared to 14% of men. These effects may include job changes, reductions in working hours, or parental leave.
Sources: en.wikipedia.org
The company's earliest stores included its original site in Rittenhouse Square as well as its New York City, Chicago, and Washington, D.C. locations. Locations in New York were opened in 2007 and 2009 in Tribeca and SoHo, respectively. The first location in Chicago was opened in 2011. The second Philadelphia location was opened in Dilworth Park (near Philadelphia City Hall) in 2011. In 2013, the company operated three locations in Seoul, South Korea. Headquarters moved to a new construction in Fishtown, Philadelphia in 2015. The construction had been voted on by residents in 2013. The same year, the company announced plans to expand to 150 new locations in the next three to four years. Expansion to Boston began in September 2015. Expansion to Los Angeles was announced in early 2016, with locations in Beverly Hills and Silver Lake. New locations in Chinatown, Washington, D.C. and Lincoln Park, Chicago were announced in 2016. In San Diego, a new location opened in Westfield UTC in fall 2017. In 2021, a location was announced in Austin, Texas inside a Whole Foods Market, the company's first Texas location. In 2025, both locations in Boston closed (at 745 Atlantic Ave. in Leather District and at 29 Northern Ave. in the Seaport District), with the owners citing financial performance of the locations and other factors. As of 2025, La Colombe advertises on its website 30 locations in the United States, in Philadelphia, New York City, Washington, D.C., Boston, Chicago, Austin, Los Angeles, and San Diego.
Cushing's syndrome is classified as either pituitary-dependent, adrenal-dependent, or iatrogenic. Pituitary-dependent Cushing's is caused by an adrenocorticotropic hormone producing pituitary tumour. Adrenal-dependent Cushing's is caused by an adrenal tumour. Pituitary-dependent Cushing's accounts for 80-85% of cases. Other forms have been described but they appear to be rare. Ectopic adrenocorticotropic hormone secretion has been described in a German Shepherd dog, those reviewing the case noted it could be the result of an abdominal neuroendocrine tumour. In one case a Vizsla was diagnosed with food-dependent hypercortisolemia.
Election results (National Assembly) Election results (Elections Quebec) Maps 2001 map (Flash) 2001–2011 changes (Flash) 1992–2001 changes (Flash) Electoral map of Laurentides region (as of 2001) Quebec electoral map, 2001
Aluminon, the triammonium salt of aurintricarboxylic acid, is a dye often used to detect the presence of the aluminium ion in an aqueous solution. Aluminon forms a red complex salt in combination with Al3+. In addition to its use in qualitative inorganic analysis, aluminon has applications in pigment production. It forms brilliantly colored lake pigments with many metals. The pigments are red in combination with Be2+ and Ga3+. The pigment is deep purple or reddish-brown in combination with Fe3+. Color of a particular pigment in acidic solutions may change: aluminon and Sc3+ form red pigments if the solution is acidic, but otherwise the solutions are colorless. Aluminon is prepared by reacting sodium nitrite with salicylic acid, adding formaldehyde, then treating with ammonia. Analytical chemistry Colorimetry
C-5 sterol desaturase couples sterol oxidation to the oxidation of NAD(P)H and the reduction of molecular oxygen. Either NADH or NADPH can be used; in the model plant species Arabidopsis thaliana C-5 sterol desaturase catalyzes the reaction twice as fast with NADH while in S. cerevisiae the enzyme has little preference. The precise details of the reaction have been thought to vary between mammals and yeast. However, the enzymes do share a conserved cluster of histidine residues, which when mutated (in A. thaliana) dramatically reduce or eliminate enzyme activity, suggesting the involvement of a coordinated iron cation in the mechanism. Mutagenesis studies suggest that in A. thaliana threonine 114 (which is a serine in humans, mice, and yeast) may help to stabilize the enzyme-substrate complex. Rahier has proposed a reaction mechanism in which an iron-coordinated oxygen abstracts a hydrogen from the substrate leading to a radical intermediate.
Sources: en.wikipedia.org
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.
Reversed-phase liquid chromatography separates components and reports purity from peak area. Mass spectrometry confirms the molecular mass expected for the sequence. Additional approaches such as peptide mapping or amino acid analysis provide independent confirmation.
Reported percentages depend on the analytical method, the detection wavelength, and whether salts and water are counted. A value above ninety-five percent by chromatography does not by itself establish a correct sequence. Different suppliers also calculate purity against different reference standards.
Standard practice is a desiccated container at −20 °C, protected from light and kept sealed between uses. Letting the vial reach room temperature before opening reduces condensation on the powder. Repeated warming and cooling of the whole container is generally avoided.